Key Points Neogen’s fiscal first-quarter revenue rose 6.5% to $222.8 million, with core growth of 8.1%. Adjusted EBITDA increased 17% to $41.6 million, and adjusted…
Key Points Firefly Neuroscience will introduce NeuroSigma’s Monarch eTNS System to its nationwide network of clinicians who use the Evoke platform. Monarch is an FDA-cleared,…
September 25, 2026
STAAR Surgical Authorizes $50 Million Stock Buyback, Citing Cash Position and Business Progress
Key Points STAAR Surgical authorized the repurchase of up to $50 million of its common stock. The program is expected to run for about 12…
September 21, 2026
QinFlow Launches PressSure™, Targeting One of Critical Care’s Most Persistent Manual Tasks
QinFlow (Private — no public ticker) rolls out a battery-powered pressure management device for blood and IV fluid delivery PLANO, Texas — September 21,…
September 11, 2026
NRx’s HOPE Therapeutics Prepares First Robotic TMS Deployment in Florida
Key Points NRx Pharmaceuticals’ HOPE Therapeutics subsidiary is preparing to deploy Zeta Surgical’s FDA-cleared robotic transcranial magnetic stimulation, or TMS, system in Florida clinics. HOPE…
September 08, 2026
BrainsWay Pilot Study Links Deep TMS to Depression Improvement in Early Alzheimer’s Patients
Key Points BrainsWay reported results from a 12-patient pilot study of Deep TMS in people with major depressive disorder and early-stage Alzheimer’s disease. After 36…
August 27, 2026
NeuroOne Advances StereoCED Brain Drug Delivery Platform With Successful Robotic Procedures
Key Points NeuroOne completed three robotic-assisted large-animal StereoCED procedures. Two procedures combined targeted drug delivery with intracranial electrophysiological recording from the same brain region. The…
Key Points InspireMD expects potential FDA decisions in Q4 2026 for the CGuard Prime 80 cmsystem for transcarotid artery revascularization, or TCAR, and its original CGuard carotid artery…
July 29, 2026
Pulse Biosciences Hits Its Stride: NANOPULSE‑AF AFib Pivotal Trial Passes Enrollment Midpoint
The NANOPULSE‑AF study is evaluating the CellFX nano‑second pulsed field ablation (nsPFA) Cardiac Catheter System in people with drug‑resistant, symptomatic paroxysmal atrial fibrillation. The trial…
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) is expanding beyond its traditional biotech focus with a small but strategic move into medical devices, agreeing to acquire Israeli…
Boston Scientific (NYSE: BSX) recently delivered a robust first-quarter performance characterized by double-digit revenue growth across its core medical device portfolio. This strong start for…
Noah Labs has secured FDA Breakthrough Device designation for its AI voice-based heart failure monitoring software, positioning the company as an emerging player in the…